Previous studies have shown that the transient depletion of CD11c+ DCs, including cDC1, cDC2, and Mo-DCs/DC3, inhibited Ag-specific priming of CD8+ T cells in tumor tissues (62). This evidence concerns the gene ITGAX and neoplasm.